Log in

ETR:BAYNBayer Stock Price, Forecast & News

€66.15
+3.45 (+5.50 %)
(As of 06/5/2020 04:00 PM ET)
Add
Compare
Today's Range
€63.35
Now: €66.15
€66.28
50-Day Range
€55.76
MA: €59.49
€65.32
52-Week Range
€44.86
Now: €66.15
€78.34
Volume5.71 million shs
Average VolumeN/A
Market Capitalization$64.99 billion
P/E Ratio14.98
Dividend Yield4.86%
BetaN/A
Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, cosmetics, and self-care solutions in the dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, cold and cough, foot care, and sun protection categories. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The Animal Health segment develops and markets products and solutions for the prevention and treatment of disease in companion and farm animals to veterinarians. Bayer Aktiengesellschaft has a collaboration agreement with MD Anderson Cancer Center at the University of Texas to develop cancer treatments; and research collaboration agreements with Haplogen GmbH and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. The company distributes its products through wholesalers, pharmacies, supermarket and drugstore chains, online and other retailers, and hospitals, as well as directly to farmers. It has strategic research alliance with Kyoto University to jointly identify new drug targets for the treatment of pulmonary diseases, such as idiopathic pulmonary fibrosis. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.3Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.41 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone49 214 30 1

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$44.14 billion
Cash Flow€5.47 per share
Book Value€49.48 per share

Profitability

Miscellaneous

Employees111,015
Market Cap$64.99 billion
Next Earnings Date8/4/2020 (Estimated)
OptionableNot Optionable

Receive BAYN News and Ratings via Email

Sign-up to receive the latest news and ratings for BAYN and its competitors with MarketBeat's FREE daily newsletter.

Bayer (ETR:BAYN) Frequently Asked Questions

How has Bayer's stock been impacted by COVID-19 (Coronavirus)?

Bayer's stock was trading at €56.07 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BAYN stock has increased by 18.0% and is now trading at €66.15. View which stocks have been most impacted by Coronavirus.

When is Bayer's next earnings date?

Bayer is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Bayer.

Has Bayer been receiving favorable news coverage?

News headlines about BAYN stock have been trending negative this week, according to InfoTrie Sentiment. The research firm identifies positive and negative media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Bayer earned a media sentiment score of -2.1 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 3.0 out of 10, indicating that recent media coverage is unlikely to have an impact on the stock's share price in the next several days. View the latest news aboutBayer.

Who are some of Bayer's key competitors?

What other stocks do shareholders of Bayer own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bayer investors own include Delta Air Lines (DAL), Kraft Heinz (KHC), American Express (AXP), General Electric (GE), Mastercard (MA), Chevron (CVX), Coca-Cola (KO), 3M (MMM), SAP (SAP) and Total (TOT).

Who are Bayer's key executives?

Bayer's management team includes the following people:
  • Mr. Werner Baumann, Chairman of Management & CEO (Age 57)
  • Mr. Wolfgang U. Nickl, CFO & Member of Management Board (Age 50)
  • Mr. Liam Condon, Pres of Bayer Crop Science Division & Member of Management Board (Age 51)
  • Dr. Kemal Malik, Head of Innovation & Member of Management Board (Age 57)
  • Dr. Hartmut Klusik, Head of HR, Technology & Sustainability, Labor Director and Member of Management Board (Age 63)

What is Bayer's stock symbol?

Bayer trades on the ETR under the ticker symbol "BAYN."

What is Bayer's stock price today?

One share of BAYN stock can currently be purchased for approximately €66.15.

How big of a company is Bayer?

Bayer has a market capitalization of $64.99 billion and generates $44.14 billion in revenue each year. Bayer employs 111,015 workers across the globe.

What is Bayer's official website?

The official website for Bayer is www.bayer.com.

How can I contact Bayer?

The company can be reached via phone at 49 214 30 1.

This page was last updated on 6/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.